No profile data available.
Bio-Techne Corporation (TECH) is a healthcare company in the biological analysis equipment industry, based in Minneapolis, United States, with about 3,000 full-time employees.
It reported revenue of $1.22 billion for fiscal year 2026, down 0.4% from fiscal year 2025, and net income of $181.84 million. Its largest business segment, Protein Sciences, brought in 72% of segment revenue in fiscal year 2026; United States was the largest region with 52%. Its market capitalization was $11.36 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.
Bio-Techne reported $1.22 billion in revenue for fiscal year 2026, down 0.4% from $1.22 billion in fiscal year 2025.
Protein Sciences, with $874.62 million or 72% of segment revenue in fiscal year 2026. Next: Diagnostics and Spatial Biology (28%) and Other Revenue (under 1%).
United States: 52% of revenue by region in fiscal year 2026, followed by EMEA, Excluding United Kingdom (24%).
$11.36 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Illumina, Inc. (ILMN), Mettler-Toledo International Inc. (MTD), Revvity, Inc. (RVTY), Repligen Corporation (RGEN).